A new wearable wristband could significantly improve diabetes management by continuously tracking not only glucose but also other chemical and cardiovascular signals that influence disease progression and overall health. The technology was published in Nature Biomedical Engineering.

Study to Evaluate Renal Denervation Therapy’s Potential Benefits Beyond Hypertension Across Multiple Organ Systems

Innovative software platform leverages artificial intelligence to personalize therapy decisions and improve clinical outcomes for prostate cancer patients.

AI-Powered 3D Surgical Planning Tool Advances Precision Breast Cancer Surgery with Latest Regulatory Milestone

Abbott (NYSE: ABT)+
announced that it received a Medicare win related to its TriClip TEER system.

Intuitive Surgical (Nasdaq: ISRG)+
announced today that the FDA cleared the latest advanced energy instrumentation for its da Vinci systems.

JERSEY CITY, N.J. and OR YEHUDA, Israel, July 10, 2025 /PRNewswire/ — Synchrony Medical, a medical technology company dedicated to advancing respiratory care, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its LibAirty™ Airway Clearance System in the United States.

OREM, Utah, July 10, 2025 /PRNewswire/ — Dymicron®, a privately held medical device company pioneering advanced spinal technologies, today announced that the United States (U.S.) Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to begin a pivotal clinical study of the Triadyme®–C cervical artificial disc.

The FDA has granted 510(k) clearance to the TaviPilot AI software developed by Caranx Medical, according to company officials.

Brazilian researchers have discovered chemical compounds in marine sponges that have the potential to eliminate the malaria parasite, including strains that are resistant to conventional antimalarial drugs. The research results were published in the journal ACS Infectious Diseases.